Comparison of 1-month vs. 12-month dual antiplatelet therapy after implantation of drug-eluting stents in patients with acute coronary syndrome: the ULTIMATE-DAPT trial

Eur Heart J Acute Cardiovasc Care. 2024 May 7;13(4):368-369. doi: 10.1093/ehjacc/zuae048.

Authors

Pascal Vranckx^{1

2}, Marco Valgimigli^{3

4}

Affiliations

¹ Department of Cardiology and Intensive Care, Jessa Ziekenhuis Hasselt, Hasselt, Belgium.
² Faculty of Medicine and Life Sciences, University of Hasselt, Hasselt, Belgium.
³ Cardiocentro Ticino Institute, Ente Ospedaliero Cantonale (EOC), via Tesserete 48, 6900 Lugano, Switzerland.
⁴ Department of Biomedical Sciences, University of Italian Switzerland, Via Giuseppe Buffi 13, 6900 Lugano, Switzerland.

PMID: 38598480
DOI: 10.1093/ehjacc/zuae048

No abstract available

Publication types

Randomized Controlled Trial
Comparative Study
Multicenter Study
Letter

MeSH terms

Acute Coronary Syndrome* / surgery
Acute Coronary Syndrome* / therapy
Drug-Eluting Stents*
Dual Anti-Platelet Therapy* / methods
Female
Follow-Up Studies
Humans
Male
Percutaneous Coronary Intervention* / methods
Platelet Aggregation Inhibitors* / administration & dosage
Platelet Aggregation Inhibitors* / therapeutic use
Time Factors
Treatment Outcome

Substances

Platelet Aggregation Inhibitors